IMU
LIVE

Serial Number

97479277

Owner

Melio Healthcare Limited

Attorney

Ben Natter

Filing Date

Jun 28, 2022

Add to watchlist:

No watchlists yet
View on USPTO

IMU Trademark

Serial Number: 97479277 • Registration: 8200559

IMU is a trademark filed by Melio Healthcare Limited on June 28, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Melio Healthcare Limited (2 trademarks)

c/o Mark Davies & Associates Ltd
London EC2V5DE , GB

Entity Type: 99

Trademark Details

Filing Date

June 28, 2022

Registration Date

April 7, 2026

Published for Opposition

February 17, 2026

Goods & Services

Medical apparatus and instruments, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; medical apparatus and instruments for detecting, measuring, analysing and testing biomarkers in samples, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; medical apparatus and instruments for processing and analysing biological samples, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; medical apparatus for obtaining biological samples from humans, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; blood testing apparatus, blood pressure measuring apparatus; parts and fittings for all the aforesaid goods

Medical research services; medical research laboratory services; biological research, scientific research in the nature of conducting clinical trials for others, and medical research; provision of information and data relating to medical research and medical research developments; scientific research for medical purposes; consultancy in relation to the aforesaid services

Scientific apparatus and instruments, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; measuring, detecting, analysing and testing apparatus and instruments, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; apparatus and instruments for detecting, measuring, analysing and testing biomarkers in samples, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; apparatus and instruments for processing and analysing biological samples, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; downloadable and recorded computer software and hardware for processing and analysing biological samples and biomarkers; medical research apparatus and instruments, namely, immunophenotyping devices for identifying and characterizing cell types and biomarkers; parts and fittings for all the aforesaid goods

Medical services; human healthcare services; provision of information relating to prevention, diagnosis, treatment and identification of medical and health disorders or imbalances; medical and health services relating to blood testing; medical testing services; medical testing for diagnostic or treatment services and advice related thereto; medical advisory services; telemedicine services; personalised health and wellbeing advice; consultancy, advice and information related to the aforesaid services

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 7, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 17, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 17, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 11, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 22, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 22, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 22, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 21, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 21, 2026 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 20, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 20, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 13, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 12, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 12, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 12, 2026 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Dec 10, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 9, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 9, 2025 GNSL
SUSPENSION LETTER WRITTEN
Jun 9, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 9, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 9, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 11, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 11, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 11, 2025 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 10, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 10, 2024 GNSL
SUSPENSION LETTER WRITTEN
Sep 10, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2024 CRFA
ASSIGNED TO LIE
Sep 9, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 15, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 15, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 15, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 15, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 17, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 17, 2023 GNSL
SUSPENSION LETTER WRITTEN
Jul 17, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 14, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 14, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 14, 2023 CNRT
ASSIGNED TO EXAMINER
Apr 12, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2022 NWOS
NEW APPLICATION ENTERED
Jul 1, 2022 NWAP